Medical technology company Inspire Medical Systems (NYSE:INSP) reported Q4 CY2024 results topping the market’s revenue ...
Inspire Medical Systems (NYSE:INSP – Free Report) had its price target trimmed by Morgan Stanley from $230.00 to $220.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm ...
Inspire Medical Systems (NYSE:INSP – Get Free Report) had its price objective lowered by Truist Financial from $250.00 to $235.00 in a note issued to investors on Tuesday,Benzinga reports. The ...
Q4 2024 Earnings Call Transcript February 10, 2025 Inspire Medical Systems, Inc. beats earnings expectations. Reported EPS is ...
Inc. (NYSE:INSP) by taking the expected future cash flows and discounting them to their present value. We will use the Discounted Cash Flow (DCF) model on this occasion. Models like these may appear ...
2025 Gross Margin Guidance: 84% to 86%. 2025 Diluted Net Income Per Share Guidance: $2.10 to $2.20. Inspire Medical Systems Inc (NYSE:INSP) achieved its first full year of profitability in 2024, with ...
In a report released today, Jonathan Block from Stifel Nicolaus maintained a Hold rating on Inspire Medical Systems (INSP – Research Report), ...